NAS:CUTR (USA) Also trade in: Germany

Cutera Inc

$ 17.01 -0.49 (-2.8%)
On watch
Volume: 175,046 Avg Vol (1m): 166,191
Market Cap $: 238.77 Mil Enterprise Value $: 211.67 Mil
P/E (TTM): 0.00 P/B: 6.11
Earnings Power Value 10.7
Net Current Asset Value 1.39
Tangible Book 2.7
Projected FCF 2.66
Median P/S Value 22.66
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 7/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt No Debt
Cash-To-Debt ranked higher than
98.18% of 330 companies
in the Medical Devices industry.
Industry Max: 504099, Med: 2.32, Min: -16.34
CUTR: No Debt
Ranked among companies with meaningful Cash-To-Debt only.
N/A
Equity-to-Asset 0.40
Equity-to-Asset ranked lower than
57.28% of 309 companies
in the Medical Devices industry.
Industry Max: 0.99, Med: 0.63, Min: -24.4
CUTR: 0.4
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: 0.31, Med: 0.81, Max: 0.87
Current: 0.4
0.31
0.87
Piotroski F-Score 3
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.61
DISTRESS
GREY
SAFE
Beneish M-Score -4.62
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC -120.53%
WACC 9.54%

Profitability & Growth : 5/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % -10.13
Operating Margin ranked higher than
61.86% of 312 companies
in the Medical Devices industry.
Industry Max: 1148.46, Med: 1.96, Min: -47867.72
CUTR: -10.13
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: -20.83, Med: -8.53, Max: 4.67
Current: -10.13
-20.83
4.67
Net Margin % -22.45
Net Margin ranked higher than
90.06% of 312 companies
in the Medical Devices industry.
Industry Max: 15538.12, Med: 1.4, Min: -45900
CUTR: -22.45
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: -32.93, Med: -11.03, Max: 19.8
Current: -22.45
-32.93
19.8
ROE % -63.04
ROE ranked higher than
99.01% of 304 companies
in the Medical Devices industry.
Industry Max: 51.97, Med: 0.95, Min: -2921.66
CUTR: -63.04
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: -63.04, Med: -8.95, Max: 47.64
Current: -63.04
-63.04
47.64
ROA % -34.36
ROA ranked higher than
97.59% of 332 companies
in the Medical Devices industry.
Industry Max: 1204.95, Med: -0.26, Min: -2520.55
CUTR: -34.36
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: -34.36, Med: -7.43, Max: 29.54
Current: -34.36
-34.36
29.54
ROC (Joel Greenblatt) % -128.14
ROC (Joel Greenblatt) ranked higher than
95.41% of 327 companies
in the Medical Devices industry.
Industry Max: 8175, Med: 3.87, Min: -323166.67
CUTR: -128.14
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: -1247.08, Med: -223.26, Max: 76.33
Current: -128.14
-1247.08
76.33
3-Year Total Revenue Growth Rate 19.70
3-Year Revenue Growth Rate ranked higher than
88.58% of 254 companies
in the Medical Devices industry.
Industry Max: 300.7, Med: 4.3, Min: -100
CUTR: 20.3
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: -18.1, Med: 13.75, Max: 54.9
Current: 20.3
-18.1
54.9
3-Year Total EBITDA Growth Rate -54.00
3-Year EBITDA Growth Rate ranked lower than
100.00% of 232 companies
in the Medical Devices industry.
Industry Max: 109.5, Med: 7.5, Min: -344.2
CUTR: -54.7
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
N/A
3-Year EPS w/o NRI Growth Rate -91.00
3-Year EPS w/o NRI Growth Rate ranked lower than
100.00% of 223 companies
in the Medical Devices industry.
Industry Max: 241, Med: 7.8, Min: -413
CUTR: -91
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
N/A

» CUTR's 30-Y Financials

Financials (Next Earnings Date: 2019-08-07)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:CUTR

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Devices » Medical Devices    NAICS : 334510    SIC : 3845
Compare HKSE:01358 NYSE:IVC ROCO:4107 XKRX:042520 OSL:MEDI XKRX:228850 NAS:SPNE XKRX:100120 NAS:AVDR HKSE:01696 TSE:6823 LSE:MGP TSX:VMD XKRX:099190 SZSE:300216 TPE:4104 TSE:7600 NAS:NMRD OTCPK:SMLR XKRX:060280
Traded in other countries TJ9.Germany
Address 3240 Bayshore Boulevard, Brisbane, CA, USA, 94005
Cutera Inc is a medical device company. It specializes in the design, development, manufacture, marketing and servicing of laser and other energy based aesthetics systems for practitioners internationally. Its products include Enlighten, Excel HR, Excel v, Xeo and Trusculpt 3d. The company markets and sells its products under Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis plus, Pico-genesis, Solera, Titan, Trusculpt, and Xeo trademarks. It derives majority of its revenue from United States geographic segment.

Ratios

Current vs industry vs history
PB Ratio 6.11
PB Ratio ranked lower than
89.35% of 310 companies
in the Medical Devices industry.
Industry Max: 1180, Med: 3.06, Min: 0.07
CUTR: 6.11
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 0.68, Med: 1.67, Max: 10.93
Current: 6.11
0.68
10.93
PS Ratio 1.46
PS Ratio ranked lower than
62.59% of 294 companies
in the Medical Devices industry.
Industry Max: 1136.36, Med: 3.15, Min: 0.05
CUTR: 1.46
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 0.93, Med: 1.91, Max: 5.05
Current: 1.46
0.93
5.05
Price-to-Free-Cash-Flow 226.80
Price-to-Free-Cash-Flow ranked lower than
77.57% of 107 companies
in the Medical Devices industry.
Industry Max: 3239, Med: 26.44, Min: 5.07
CUTR: 226.8
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
Price-to-Free-Cash-Flow range over the past 10 years
Min: 9.78, Med: 62.09, Max: 1266
Current: 226.8
9.78
1266
Price-to-Operating-Cash-Flow 94.48
Price-to-Operating-Cash-Flow ranked lower than
85.04% of 127 companies
in the Medical Devices industry.
Industry Max: 1586.78, Med: 20.01, Min: 3.03
CUTR: 94.48
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 9.28, Med: 53.24, Max: 2266.25
Current: 94.48
9.28
2266.25
EV-to-EBIT -12.69
EV-to-EBIT ranked lower than
85.63% of 174 companies
in the Medical Devices industry.
Industry Max: 18456.56, Med: 24.76, Min: 0.63
CUTR: -12.69
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: -4106.5, Med: -3.8, Max: 695.7
Current: -12.69
-4106.5
695.7
EV-to-EBITDA -13.80
EV-to-EBITDA ranked lower than
89.89% of 188 companies
in the Medical Devices industry.
Industry Max: 18456.56, Med: 18.14, Min: 0.62
CUTR: -13.8
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: -188.9, Med: -3.1, Max: 645.1
Current: -13.8
-188.9
645.1
EV-to-Revenue 1.31
EV-to-Revenue ranked lower than
58.25% of 309 companies
in the Medical Devices industry.
Industry Max: 17078.6, Med: 3.73, Min: 0.05
CUTR: 1.31
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: -0.2, Med: 0.8, Max: 4.8
Current: 1.31
-0.2
4.8
Current Ratio 1.66
Current Ratio ranked lower than
65.43% of 324 companies
in the Medical Devices industry.
Industry Max: 563.8, Med: 2.71, Min: 0.03
CUTR: 1.66
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 1.66, Med: 6.11, Max: 9.09
Current: 1.66
1.66
9.09
Quick Ratio 1.09
Quick Ratio ranked lower than
70.06% of 324 companies
in the Medical Devices industry.
Industry Max: 563.8, Med: 2.03, Min: 0.02
CUTR: 1.09
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 1.09, Med: 5.75, Max: 8.66
Current: 1.09
1.09
8.66
Days Inventory 127.45
Days Inventory ranked higher than
63.61% of 294 companies
in the Medical Devices industry.
Industry Max: 990.33, Med: 143.61, Min: 0.63
CUTR: 127.45
Ranked among companies with meaningful Days Inventory only.
Days Inventory range over the past 10 years
Min: 98.91, Med: 111.9, Max: 137.01
Current: 127.45
98.91
137.01
Days Sales Outstanding 42.43
Days Sales Outstanding ranked higher than
79.35% of 276 companies
in the Medical Devices industry.
Industry Max: 907.73, Med: 69.21, Min: 0.13
CUTR: 42.43
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 22.62, Med: 44.5, Max: 52.02
Current: 42.43
22.62
52.02
Days Payable 44.78
Days Payable ranked lower than
67.82% of 261 companies
in the Medical Devices industry.
Industry Max: 912.5, Med: 58.34, Min: 1
CUTR: 44.78
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 17.66, Med: 21.02, Max: 50
Current: 44.78
17.66
50

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -2.00
3-Year Share Buyback Rate ranked higher than
95.08% of 244 companies
in the Medical Devices industry.
Industry Max: 19.2, Med: -5.7, Min: -1393.3
CUTR: -2
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -13.6, Med: -2.15, Max: 3
Current: -2
-13.6
3

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 6.30
Price-to-Tangible-Book ranked lower than
78.62% of 276 companies
in the Medical Devices industry.
Industry Max: 1180, Med: 4.5, Min: 0.07
CUTR: 6.3
Ranked among companies with meaningful Price-to-Tangible-Book only.
Price-to-Tangible-Book range over the past 10 years
Min: 0.77, Med: 2.13, Max: 20.68
Current: 6.3
0.77
20.68
Price-to-Projected-FCF 6.39
Price-to-Intrinsic-Value-Projected-FCF ranked lower than
88.43% of 121 companies
in the Medical Devices industry.
Industry Max: 89.64, Med: 2.44, Min: 0.43
CUTR: 6.39
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.45, Med: 2.42, Max: 1308
Current: 6.39
0.45
1308
Price-to-Median-PS-Value 0.75
Price-to-Median-PS-Value ranked lower than
91.98% of 237 companies
in the Medical Devices industry.
Industry Max: 20.13, Med: 1.02, Min: 0.02
CUTR: 0.75
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.57, Med: 1.12, Max: 2.76
Current: 0.75
0.57
2.76
Earnings Yield (Joel Greenblatt) % -7.88
Earnings Yield (Greenblatt) ranked higher than
55.42% of 332 companies
in the Medical Devices industry.
Industry Max: 158.73, Med: 0.74, Min: -2500
CUTR: -7.88
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: -224.8, Med: -8.5, Max: 663.1
Current: -7.88
-224.8
663.1

More Statistics

Revenue (TTM) (Mil) $ 164.62
EPS (TTM) $ -2.65
Beta 1.19
Volatility % 49.29
52-Week Range $ 12.32 - 48.85
Shares Outstanding (Mil) 14.04

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 3
Positive ROA N
Positive CFROA Y
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy N